From new partnerships and launches, here are six developments from Globus Medical so far in 2025. 1. OsteoCentric Technologies entered into a non-exclusive licensing agreement with Globus Medical. OsteoCentric’s MIS Bone Preservation Tapping Technology & Instant Interlocking Thread-form is the…
Spinal Tech
Stryker’s OptaBlate, the company’s first basivertebral nerve ablation system earned FDA 510(k) clearance. OptaBlate is used for a minimally invasive, target procedure for chronic vertebrogenic low back pain, according to a May 19 news release. It achieves at least a…
Globus Medical’s board of directors authorized a share repurchase program of up to $500 million of the company’s outstanding common stock. Timing and number of repurchased shares will be determined by management based on a variety of factors including market…
From biologics to robots, here are seven spine products earning FDA nods since March 18. 1. Tenon Medical earned FDA 510(k) clearance to use its Catamaran sacroiliac joint system for augmenting thoracolumbar fusion. With the new indication Catamaran can be…
Tariffs were a key talking point among spine and orthopedic medtech leaders. Here is how five leaders are approaching the headwind, according to their first quarter earnings calls. Stryker Stryker plans to absorb the impact of tariffs, an estimated $200…
Advertisement
Genesys Spine launched the Stasys-C 3DP cervical standalone system, according to a May 14 news release. The interbody system is designed with a a non-screw-based fixation method and inserted through a direct anterior approach. It’s available in 14×12 mm and…
Six spine and orthopedic tech companies have made changes to their leadership since April 1. 1. Richard Mueller is the new president and CEO of Life Spine. Mr. Mueller was promoted from his role as COO at Life Spine, and…
EDGe Surgical, which focuses on single-use digital spine and orthopedic instruments, named Leo Carayannopoulos as CEO. Mr. Carayannopoulos’ appointment comes shortly after the company raised $1.3 million in financing, according to a May 12 news release. The company’s flagship product…
On the heels of a first quarter sales dip, leaders remain confident in Globus Medical’s full-year success, according to a May 8 earnings call. 1. Globus Medical’s Excelsius robotic technologies are now compatible with the Reline Open, Modular, Mass, Mass…
Globus Medical’s first quarter sales decreased 1.4% year over year, according to financial results posted May 8. Five things to know: 1. Quarterly sales were $598.1 million. President and CEO Dan Scavilla said sales were affected by enabling technology deal…